Drug repurposing, identifying novel indications for drugs, bypasses common drug development pitfalls to ultimately deliver therapies to patients faster. However, most …
Motivation Mining drug–disease association and related interactions are essential for developing in silico drug repurposing (DR) methods and understanding underlying …
Background Computational drug repurposing is a cost-and time-efficient approach that aims to identify new therapeutic targets or diseases (indications) of existing drugs/compounds. It …
Deep learning is rapidly advancing many areas of science and technology with multiple success stories in image, text, voice and video recognition, robotics, and autonomous …
F Zhang, W Hu, Y Liu - BMC bioinformatics, 2022 - Springer
Background The main focus of in silico drug repurposing, which is a promising area for using artificial intelligence in drug discovery, is the prediction of drug–disease relationships …
Motivation Traditional drug discovery and development are often time-consuming and high risk. Repurposing/repositioning of approved drugs offers a relatively low-cost and high …
Discovering effective therapies is difficult for neurological and developmental disorders in that disease progression is often associated with a complex and interactive mechanism …
Motivation Identification of novel therapeutic effects for existing US Food and Drug Administration (FDA)-approved drugs, drug repurposing, is an approach aimed to …
J Chan, X Wang, JA Turner, NE Baldwin, J Gu - Bioinformatics, 2019 - academic.oup.com
Motivation Transcriptome-based computational drug repurposing has attracted considerable interest by bringing about faster and more cost-effective drug discovery. Nevertheless, key …